Lung function, airway remodeling, and inflammation in infants: outcome at 8 years

Kristiina Malmström1, L Pekka Malmberg1, Ruth O'Reilly2

  • 1Department of Allergy, Helsinki University Central Hospital, Helsinki, Finland.

Insights

Infant airway disease and early lung function deficits do not predict asthma outcomes at school age. However, early respiratory symptoms and reduced lung function in infancy are linked to later asthma development and medication use.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Asthma Research

Background:

  • The relationship between early lung function deficits, infant airway disease, and school-aged respiratory outcomes in symptomatic infants remains unclear.
  • Investigating early indicators of respiratory health in infancy is crucial for understanding long-term outcomes.

Purpose of the Study:

  • To assess the predictive value of infant airway disease for respiratory outcomes at school age.
  • To report follow-up data on a unique cohort of children invasively investigated in infancy.

Main Methods:

  • Fifty-three infants with prior bronchoscopy and airway conductance measurements were reassessed at 8 years of age.
  • Lung function, airway responsiveness, and asthma medication use were evaluated.
  • Study children's lung function was compared to healthy nonasthmatic controls.

Main Results:

  • No infant pathologic feature predicted school-aged respiratory outcomes.
  • Children with current asthma showed reduced infant lung function and had parental asthma.
  • Early respiratory symptoms and reduced infant lung function were risk factors for later reduced lung function and asthma medication purchase.

Conclusions:

  • Pathologic measures in infancy lack predictive value for later asthma development.
  • The underlying processes initiating asthma may differ from those driving ongoing eosinophilic inflammation.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
21
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
5.3K
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
67.4K
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
16
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.3K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.2K